News



Rates and Dividends

It is hard to imagine how OMIC’s bottom line could be stronger. Our surplus position is arguably the best in the industry. A premium-to-surplus ratio of .19 to 1 is almost unheard of historically. At the same time, OMIC’s rates in the vast majority of the U.S. are significantly lower than our competitors and our average dividend returns during the past decade have averaged nearly three times higher than the industry.

We are able to achieve these results primarily due to our better defense of claims, lower relative operating costs, superior investment returns, and your continued support of our company. Due to OMIC’s continued healthy balance sheet, I am pleased to report that current insurance rates will be extended through 2019 in all states and territories and your Board has approved another significant policyholder dividend to be paid in 2019, equal to 15% of your 2018 annual premium.

2017 Dividend
Declared dividend was 19.8% of earned premium (vs. 5.7% for industry).
(approx $8 Million)

Cumulative Dividends
5 Year 77.7% 10 Year 181.5%

Tim Padovese
OMIC President and CEO

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment



Six reasons OMIC is the best choice for ophthalmologists in America.

#2. Leader in the industry.

A-rated by AM Best, OMIC is ranked #1 among 50 malpractice insurance companies in America for financial stability. No other carrier has matched OMIC's consistent financial performance with regard to both combined and operating ratios, the two most relevant financial measurements for an insurance carrier.

61864684